Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before

Author： Mancuso Cesare   Siciliano Raffaella   Barone Eugenio   Butterfield David Allan   Preziosi Paolo  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.9, 2011-09, pp. : 1243-1261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?

By Saxena Uday  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 12, 2010-12 ,pp. : 1273-1277

Informa Healthcare

Access to resources Recommend Favorite

Combination Therapy for Alzheimer's Disease

By Patel Laxeshkumar   Grossberg George T.  

Drugs & Aging, Vol. 28, Iss. 7, 2011-07 ,pp. : 539-546

Adis International

Access to resources Recommend Favorite

Update on drug therapy for Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1338, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Peptides for Therapy and Diagnosis of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 6, 2012-02 ,pp. : 755-767

Bentham Science Publishers

Access to resources Recommend Favorite

Compliance-Guided Therapy: A New Insight Into the Potential Role of Clinical Pharmacologists

By Blesius Alexia  

Clinical Pharmacokinetics, Vol. 45, Iss. 1, 2006-01 ,pp. : 95-104

Adis International

Access to resources Recommend Favorite